DIVERSIFIED HEALTHCARE TRUST — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that DIVERSIFIED HEALTHCARE TRUST filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $278.57M | Feb 27, 2018 |
| FY2017 | Sep 30, 2017 | $266.68M | Feb 27, 2018 |
| FY2017 | Jun 30, 2017 | $265.01M | Feb 27, 2018 |
| FY2017 | Mar 31, 2017 | $264.56M | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $274.30M | Feb 27, 2018 |
| FY2017 | Sep 30, 2016 | $263.98M | Feb 27, 2018 |
| FY2017 | Jun 30, 2016 | $261.37M | Feb 27, 2018 |
| FY2017 | Mar 31, 2016 | $258.38M | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | $267.52M | Feb 27, 2017 |
| FY2016 | Sep 30, 2015 | $255.28M | Feb 27, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.50B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $1.41B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.28B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.38B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $1.63B | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $256.04M | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | $255.83M | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | $262.00M | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $266.29M | Mar 2, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($285.89M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($370.26M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($293.57M) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($15.77M) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $174.52M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | ($139.45M) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | ($51.70M) | Mar 2, 2020 |
| FY2019 | Sep 30, 2019 | ($29.39M) | Mar 2, 2020 |
| FY2019 | Jun 30, 2019 | ($37.23M) | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $30.08M | Mar 2, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $275.20M | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $303.08M | Feb 27, 2018 |
| FY2017 | Dec 31, 2015 | $313.53M | Feb 27, 2018 |
| FY2016 | Dec 31, 2014 | $291.39M | Feb 27, 2017 |
| FY2015 | Dec 31, 2013 | $264.51M | Feb 24, 2016 |
| FY2014 | Dec 31, 2012 | $254.08M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $223.40M | Mar 3, 2014 |
| FY2012 | Dec 31, 2010 | $198.28M | Feb 19, 2013 |
| FY2010 | Dec 31, 2009 | $180.70M | Feb 24, 2011 |
| FY2010 | Dec 31, 2008 | $152.71M | Feb 24, 2011 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($19.62M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $112.22M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $10.48M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($40.35M) | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | ($63.32M) | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $158.54M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $265.85M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $392.84M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $419.30M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $424.48M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.36B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $5.14B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $5.45B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $6.00B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $6.62B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $6.48B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $6.65B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $7.16B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $7.29B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $7.23B | Mar 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.70B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.18B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $3.11B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.36B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $3.96B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $3.86B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $3.78B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $3.98B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $4.02B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.03B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.67B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.96B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.34B | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | $2.64B | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | $2.66B | Feb 25, 2025 |
| FY2021 | Dec 31, 2020 | $2.50B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.74B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $3.02B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $3.10B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.20B | Feb 27, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.12B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.41B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.78B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $2.07B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $2.09B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.91B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.05B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.14B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.77B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.62B | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.41M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $144.58M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $245.94M | Feb 24, 2026 |
| FY2023 | Jun 30, 2023 | $338.43M | Feb 26, 2024 |
| FY2024 | Dec 31, 2022 | $658.07M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $634.85M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $74.42M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $37.36M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $54.98M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $31.24M | Mar 2, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.44B | Feb 24, 2026 |
| FY2024 | Dec 31, 2024 | $3.05B | Feb 25, 2025 |
| FY2018 | Dec 31, 2018 | $3.68B | Mar 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 24, 2022 |
| FY2016 | Dec 31, 2016 | 0 | Feb 27, 2017 |
| FY2016 | Sep 30, 2016 | 0 | Feb 27, 2017 |
| FY2016 | Jun 30, 2016 | 0 | Feb 27, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (1) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 24, 2022 |
| FY2010 | Dec 31, 2010 | 0 | Feb 24, 2011 |
| FY2010 | Dec 31, 2009 | 0 | Feb 24, 2011 |
| FY2010 | Dec 31, 2008 | 1 | Feb 24, 2011 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 242.12M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 241.27M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | 240.42M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 239.69M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | 238.99M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 238.27M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 237.90M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 237.73M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 237.63M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 237.54M | Feb 27, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.66M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $9.63M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $9.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $9.57M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $9.54M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $42.83M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $199.72M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $370.75M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $370.61M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $370.49M | Mar 1, 2019 |